| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-8993(97)01408-X |
| P953 | full work available online at | https://api.elsevier.com/content/article/PII:S000689939701408X?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S000689939701408X?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 9554968 |
| P2093 | author name string | C. R. Freed | |
| K. P. Bell | |||
| F. S. Adams | |||
| E. D. Clarkson | |||
| W. M. Zawada | |||
| D. J. Zastrow | |||
| P2860 | cites work | GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons | Q24336322 |
| Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 | ||
| Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) | Q28202629 | ||
| Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo | Q28306009 | ||
| Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system | Q34248307 | ||
| Apoptosis in substantia nigra following developmental striatal excitotoxic injury | Q35683281 | ||
| Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease | Q39111166 | ||
| Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease | Q39519102 | ||
| The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum | Q41106061 | ||
| Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain | Q41379201 | ||
| The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture | Q42497537 | ||
| Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF | Q44115340 | ||
| Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. | Q45942003 | ||
| Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. | Q46172163 | ||
| Single topical application of human recombinant basic fibroblast growth factor (rbfgf) promotes neovascularization in rat cerebral cortex | Q48300073 | ||
| Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease | Q48405890 | ||
| Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease | Q48405897 | ||
| Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro | Q48444593 | ||
| The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia | Q48641595 | ||
| In situ nick end-labeling detects necrosis of hippocampal pyramidal cells induced by kainic acid | Q48963973 | ||
| Growth Factors Rescue Embryonic Dopamine Neurons from Programmed Cell Death | Q59741464 | ||
| Quantification of angiogenesis due to basic fibroblast growth factor in a modified rabbit corneal model | Q67561247 | ||
| Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year | Q68772556 | ||
| Development of intracerebral dopaminergic grafts: a combined immunohistochemical and autoradiographic study of its time course and environmental influences | Q70416558 | ||
| Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon | Q70911547 | ||
| Programmed cell death in developing grafts of fetal substantia nigra | Q72716517 | ||
| Estimation of nuclear population from microtome sections | Q82126847 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 96-103 | |
| P577 | publication date | 1998-03-01 | |
| 1998-03-09 | |||
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats | |
| P478 | volume | 786 |
| Q52716342 | A Combination of NT-4/5 and GDNF Is Favorable for Cultured Human Nigral Neural Progenitor Cells. |
| Q38784743 | A Subpopulation of Dopaminergic Neurons Coexpresses Serotonin in Ventral Mesencephalic Cultures But Not After Intrastriatal Transplantation in a Rat Model of Parkinson's Disease |
| Q40765116 | Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures |
| Q44535345 | Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells |
| Q46221982 | Ascorbic acid increases the number of dopamine neurons in vitro and in transplants to the 6-OHDA-lesioned rat brain |
| Q35165422 | Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations |
| Q40959151 | Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death |
| Q44041634 | Caspase inhibition by Z-VAD increases the survival of grafted bone marrow cells and improves functional outcome after MCAo in rats |
| Q46633370 | Caspase inhibition increases survival of neural stem cells in the gastrointestinal tract |
| Q48308615 | Caspase inhibition reduces apoptosis and increases survival of nigral transplants |
| Q48894191 | Cell implantation therapies for Parkinson's disease using neural stem, transgenic or xenogeneic donor cells |
| Q34272298 | Cell transplantation as a treatment for retinal disease |
| Q34766680 | Cellular cardiomyoplasty--a novel approach to treat heart disease |
| Q28206557 | Cellular replacement therapy for Parkinson's disease--where we are today? |
| Q30871360 | Characterisation of cell damage and death in embryonic mesencephalic tissue: a study on ultrastructure, vital stains and protease activity |
| Q43873807 | Combined neurotrophic supplementation and caspase inhibition enhances survival of fetal hippocampal CA3 cell grafts in lesioned CA3 region of the aging hippocampus |
| Q46625527 | Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient |
| Q48270991 | Cytometric catheter for neurosurgical applications. |
| Q50574015 | Deferoxamine Preconditioning of Neural-Like Cells Derived from Human Wharton's Jelly Mesenchymal Stem Cells as a Strategy to Promote Their Tolerance and Therapeutic Potential: An In Vitro Study |
| Q33809293 | Development of fetal neural transplantation as a treatment for Parkinson's disease |
| Q53016526 | Development of rat embryonic spinal ganglion cells in damaged nerve. |
| Q38979736 | Differential behavioral outcomes following neonatal versus fetal human retinal pigment epithelial cell striatal implants in parkinsonian rats. |
| Q48098723 | Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants. |
| Q42773447 | Direct isolation and RNA-seq reveal environment-dependent properties of engrafted neural stem/progenitor cells |
| Q35648129 | Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials |
| Q48198394 | Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease. |
| Q44760131 | Dopaminergic neurons associate with blood vessels in neural transplants |
| Q40619846 | Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neuroche |
| Q44722641 | Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study |
| Q44668539 | Effects of acetylcholinesterase and butyrylcholinesterase on cell survival, neurite outgrowth, and voltage-dependent calcium currents of embryonic ventral mesencephalic neurons |
| Q73247363 | Enhancement of nigral graft survival in rat brain with the systemic administration of synthetic fibronectin peptide V |
| Q36569721 | Environmental cues to guide stem cell fate decision for tissue engineering applications |
| Q73165687 | Exposure of foetal mesencephalic cells to bone morphogenetic protein-2 enhances the survival of dopaminergic neurones in rat striatal grafts |
| Q44551336 | Fetal hippocampal CA3 cell grafts enriched with fibroblast growth factor-2 exhibit enhanced neuronal integration into the lesioned aging rat hippocampus in a kainate model of temporal lobe epilepsy |
| Q34458450 | Fetal tissue transplantation for patients with Parkinson's disease: a database of published clinical results |
| Q57675877 | Flunarizine improves the survival of grafted dopaminergic neurons |
| Q40885664 | Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons. |
| Q73387823 | Glial cell line—derived neurotrophic factor—supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage |
| Q37361384 | Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy. |
| Q43864491 | Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon |
| Q93173865 | Harnessing stem cells and biomaterials to promote neural repair |
| Q34545459 | Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning |
| Q35159463 | Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation |
| Q73229472 | Impact of a preceding striatal excitotoxic lesion and treatment with ciliary neurotrophic factor on striatal graft survival |
| Q34171271 | Impact of degradable macromer content in a poly(ethylene glycol) hydrogel on neural cell metabolic activity, redox state, proliferation, and differentiation |
| Q34120728 | Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinson's disease |
| Q51612433 | In vitro and in vivo effects of Ginkgo biloba extract EGb 761 on seeded Schwann cells within poly(DL-lactic acid-co-glycolic acid) conduits for peripheral nerve regeneration |
| Q44465323 | In vivo evaluation of pharmacologically active microcarriers releasing nerve growth factor and conveying PC12 cells |
| Q48466403 | Inhibition of JNK increases survival of transplanted dopamine neurons in Parkinsonian rats |
| Q31873495 | Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons |
| Q35099084 | Insulin-Like Growth Factor I and the Pathogenesis of Delirium: A Review of Current Evidence |
| Q44536838 | Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease |
| Q40262574 | Localization of nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor in nestin-expressing reactive astrocytes in the caudate-putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/Bl mice. |
| Q34544040 | Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells |
| Q36528697 | Maintenance of Viability and Function of Rat Islets With the Use of ROCK Inhibitor Y-27632. |
| Q34546178 | Mild hypothermia combined with neural stem cell transplantation for hypoxic-ischemic encephalopathy: neuroprotective effects of combined therapy |
| Q40347098 | Neonatal human retinal pigment epithelial cells secrete limited trophic factors in vitro and in vivo following striatal implantation in parkinsonian rats |
| Q36905553 | Neural Precursor Cells Cultured at Physiologically Relevant Oxygen Tensions Have a Survival Advantage Following Transplantation |
| Q57133786 | Neural precursor cells form integrated brain-like tissue when implanted into rat cerebrospinal fluid |
| Q44327715 | Neural stem cells and alcohol |
| Q36618160 | Neural stem cells for the treatment of disorders of the enteric nervous system: strategies and challenges |
| Q48269394 | Neurobehavioral assessment of transplanted porcine Sertoli cells into the intact rat striatum |
| Q73247360 | Neuroimmunophilin ligand enhances neurite outgrowth and effect of fetal dopamine transplants |
| Q39035207 | Neuroprotective effects of GDNF-expressing human amniotic fluid cells |
| Q35681491 | Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration |
| Q40636683 | Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons |
| Q59132577 | Neurotrophic factor-based strategies to enhance survival and differentiation of neural progenitor cells toward the dopaminergic phenotype |
| Q36225073 | New therapeutic approaches to Parkinson's disease including neural transplants. |
| Q36998339 | Overexpression of Bcl-2 promotes survival and differentiation of neuroepithelial stem cells after transplantation into rat aganglionic colon |
| Q90180957 | Peptide-Based Scaffolds for the Culture and Transplantation of Human Dopaminergic Neurons |
| Q44465582 | Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro. |
| Q48422380 | Porcine fetal ventral mesencephalic cells are targets for primed xenoreactive human T cells |
| Q64117135 | Preconditioning of Mesenchymal Stem Cells with Non-Toxic Concentration of Hydrogen Peroxide Against Oxidative Stress Induced Cell Death: The Role of Hypoxia-Inducible Factor-1 |
| Q44574700 | Pretreatment of donor cells with FGF-2 enhances survival of fetal hippocampal CA3 cell transplants in the chronically lesioned young adult hippocampus |
| Q46921956 | Primate adult brain cell autotransplantation produces behavioral and biological recovery in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian St. Kitts monkeys |
| Q39973294 | Primate adult brain cell autotransplantation, a pilot study in asymptomatic MPTP-treated monkeys |
| Q44369863 | Production of dopaminergic neurons for cell therapy in the treatment of Parkinson's disease |
| Q28138668 | Prospects for new restorative and neuroprotective treatments in Parkinson's disease |
| Q34515354 | Prospects for the treatment of Parkinson's disease using neurotrophic factors |
| Q44931892 | Reassessment of caspase inhibition to augment grafted dopamine neuron survival |
| Q35186795 | Retinal transplantation: progress and problems in clinical application |
| Q40738969 | Role of mitochondria in serum withdrawal-induced apoptosis of immortalized neuronal precursors |
| Q77697966 | Sertoli cell transplants: their use in the treatment of neurodegenerative disease |
| Q48259125 | Sertoli cells enhance the survival of co-transplanted dopamine neurons |
| Q41008595 | Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats |
| Q36729217 | Strategies for promoting anti-seizure effects of hippocampal fetal cells grafted into the hippocampus of rats exhibiting chronic temporal lobe epilepsy. |
| Q48240147 | Survival of expanded dopaminergic precursors is critical for clinical trials |
| Q48553406 | Temporal analysis of cytokine gene expression during infiltration of porcine neuronal grafts implanted into the rat brain |
| Q40744339 | Temporal changes in the neurotrophic environment of the denervated striatum as determined by the survival and outgrowth of grafted fetal dopamine neurons |
| Q39604761 | The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG-based hydrogel: Protein distribution and the glial response. |
| Q51601579 | The effects of low-intensity ultrasound on peripheral nerve regeneration in poly(DL-lactic acid-co-glycolic acid) conduits seeded with Schwann cells |
| Q44931884 | The effects of transforming growth factor-beta2 on dopaminergic graft survival. |
| Q39438497 | The enhancement of neural stem cell survival and growth by coculturing with expanded Sertoli cells in vitro |
| Q34120740 | The primate model of Parkinson's disease: its usefulness, limitations, and importance in directing future studies |
| Q44272609 | The release of excitatory amino acids, dopamine, and potassium following transplantation of embryonic mesencephalic dopaminergic grafts to the rat striatum, and their effects on dopaminergic neuronal survival in vitro |
| Q37030300 | Transcription factor Six2 mediates the protection of GDNF on 6-OHDA lesioned dopaminergic neurons by regulating Smurf1 expression |
| Q24532097 | Transplantation of hypocretin neurons into the pontine reticular formation: preliminary results |
| Q35243291 | Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system |
Search more.